Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching to tenofovir alafenamide (TAF) versus continuing tenofovir disoproxil fumarate (TDF) in virologically suppressed adults with chronic hepatitis B virus (HBV) infection.
Epistemonikos ID: be0a1c9c1b7a0822e1efd828acd326180086768e
First added on: Nov 24, 2021